Walleye Trading LLC Vertex Pharmaceuticals Inc Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $36.5 Million - $40.2 Million	79,400 Added 4178.95%	81,300 $37.8 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $8.64 Million - $10.7 Million	-22,000 Reduced 92.05%	1,900 $890,000
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $44 Million - $48.2 Million	-108,000 Reduced 81.88%	23,900 $9.99 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $20.6 Million - $24.6 Million	60,000 Added 83.45%	131,900 $53.7 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $19.6 Million - $21 Million	57,900 Added 413.57%	71,900 $25 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $1.6 Million - $1.79 Million	-5,100 Reduced 26.7%	14,000 $4.93 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $2.35 Million - $2.68 Million	8,300 Added 76.85%	19,100 $6.02 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $1.49 Million - $1.67 Million	5,200 Added 92.86%	10,800 $3.12 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $4.93 Million - $5.5 Million	-18,000 Reduced 76.27%	5,600 $1.62 Million
Q2 2022 Aug 08, 2022	SELL	$234.96 - $292.55 $3.1 Million - $3.86 Million	-13,200 Reduced 35.87%	23,600 $6.65 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $3.12 Million - $3.68 Million	14,100 Added 62.11%	36,800 $9.6 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $3.2 Million - $4.04 Million	-18,100 Reduced 44.36%	22,700 $4.99 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $5.53 Million - $6.19 Million	30,500 Added 296.12%	40,800 $7.4 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $787,458 - $928,620	-4,200 Reduced 28.97%	10,300 $2.08 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $4.47 Million - $5.21 Million	-21,600 Reduced 59.83%	14,500 $3.12 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $4.22 Million - $5.63 Million	20,400 Added 129.94%	36,100 $8.53 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $1.56 Million - $1.85 Million	-6,100 Reduced 27.98%	15,700 $4.27 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $3.27 Million - $4.29 Million	-14,500 Reduced 39.94%	21,800 $6.33 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $1.58 Million - $1.96 Million	7,900 Added 27.82%	36,300 $8.64 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $3.05 Million - $4.1 Million	18,300 Added 181.19%	28,400 $6.22 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $116,361 - $130,963	700 Added 7.45%	10,100 $1.71 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $213,993 - $247,481	-1,300 Reduced 12.15%	9,400 $1.72 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $409,325 - $486,750	-2,500 Reduced 18.94%	10,700 $1.97 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $364,584 - $461,304	2,400 Added 22.22%	13,200 $2.19 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $1.29 Million - $1.48 Million	7,700 Added 248.39%	10,800 $2.08 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $451,732 - $526,876	3,100 New	3,100 $527,000

Others Institutions Holding VRTX

# of Institutions

1,718

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.6 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.9 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.54 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.22 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account